“…Although it is difficult to ascribe all of these effects to the actions of nicotine as compared with other tobacco components (Hockertz et al, 1994;Johnson et al, 1990;, some of the effects of smoking on immune function are clearly attributable to the direct actions of nicotine (Geng, Savage, Johnson, Seagrave, & Sopori, 1995;Geng, Savage, Razani-Boroujerdi, & Sopori, 1996;McAllister-Sistilli et al, 1998;, and the degree of immunosuppression is directly related to the nicotine content of the cigarettes (McAllister-Sistilli et al, 1998;. Human lymphocytes and polymorphonuclear cells contain mRNA encoding the subunits of the nicotinic acetylcholine receptor (Benhammou et al, 2000;Hiemke et al, 1996;Mihovilovic et al, 1998), and radioligand binding confirms that nicotinic acetylcholine receptors are present on lymphocytes in humans and rodents (Benhammou et al, 2000;Maslinski, Grabczewska, & Ryzewski, 1980;Maslinski, Laskowska-Bozek, & Ryzewski, 1992;Toyabe et al, 1997). The receptors are upregulated in smokers (Benhammou et al, 2000) and are increased when lymphocytes undergo mitogenic stimulation in accord with involvement in lymphocyte activation (Paldi-Haris, Szelenyi, Nguyen, & Hollan, 1990;Szelenyi, Paldi-Haris, & Hollan, 1987), and indeed, nicotine elicits mobilization of intracellular calcium in lymphocytes, leading T-cells to release cytokines (Goud, Zhang, & Kaplan, 1993;Petro, Schwartzbach, & Zhang, 1999;Zhang, & Petro, 1996).…”